Next Investors logo grey

As scams increase, YPB offers free counterfeit protection to combat COVID-19


Published 20-MAR-2020 10:56 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

You’d think in this day and age, people would come together in times of crisis to help those in need, not to rip them off.

However, panic has set in and on top of unnecessary bulk buying of toilet paper and other essentials, new types of scams have also arisen.

According to Roland Bleyer, founder of Australia's largest independent credit card comparison site,, community fear and panic around the coronavirus is driving an increase in online sales and fraud as people opt to shop online rather than instore.

"Online sales are experiencing surges across the country as well as overseas in response to panic buying," Bleyer said.

"Unfortunately we are also seeing a rise in scam websites marketing essential products and expensive miracle virus remedies," Bleyer added.

"Some of these scams are also undertaking phishing expeditions trying to get you to give them your personal information as well as credit card details.

Cybersecurity firm Check Point stated a few days ago that over 4,000 coronavirus-related domains – sites that contain the words corona or covid – have been registered since the beginning of 2020.

"People need to be very careful. While online shopping is encouraged as it assists people to access the items they need without having to go into store, everyone needs to be on high alert," Bleyer said.

"Be very careful to ensure the businesses you shop with, are legitimate and your credit card and personal details are safe."

Curtailing counterfeit

Meanwhile, global counterfeiters are taking advantage of the worldwide panic, producing and selling fake face masks and Covid-19 testing kits.

Chinese authorities have shut down more than 80 shops on e-commerce platform Taobao, run by Alibaba, for selling counterfeit masks, and police found 100,000 fake masks during a raid of an underground factory in Shanghai in early February.

In recent weeks, there has been widespread reporting of the sale and distribution of fake face masks, usually counterfeit versions of the popular N95 variant made by 3M.

US Customs officials uncovered six plastic bags containing fake Covid-19 testing kits in a package sent from the UK on March 12.

However, with the virus showing no signs of slowing down, more fake sellers are likely to surface on e-commerce sites faster than they can be shut down, especially as people continue to stockpile masks or buy thousands at once to send to family and friends in parts of the world that have run out.

Supplies of the authentic product are now dangerously low and demand is higher than ever.

To help combat this, YPB Group (ASX:YPB) is offering manufacturers of both masks and tests their technology free to help control the rapid spread of fake products.

“We urge manufacturers, no matter where they are, to contact our office via our website – – and we will provide them with our tracer technology to incorporate into their products,” CEO John Houston said.

YBP Group will provide pocket-sized, handheld portable scanners to hospitals, government agencies and other front-line services, globally and at cost to allow them to confirm the authenticity of face masks and testing kits they are using.

YPB’s T2 invisible tracer technologies are invisible to the human eye, indestructible and can be integrated into polymers, yarn, plastic and ink, and has been certified as safe to EU and FDA standards. “We know that it will take many months for Governments to manage the transmission of this virus and it is vital that emergency services and hospitals have authentic product,” Houston said.

“The longer this goes on, the more counterfeit product will be produced. Our technologies can prevent this and YPB Group is willing to assist with our patented technology. This is an extension of my long-held desire to use our unique technologies for humanity.”

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.